Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INT2104 |
Trade Name | |
Synonyms | INT-2104|INT 2104 |
Drug Descriptions |
INT2104 comprises a lentiviral vector that transduces CD7-expressing T-cells with a chimeric antigen receptor (CAR) targeting CD20, potentially resulting in depletion of B-cells and tumor growth inhibition (Journal for ImmunoTherapy of Cancer 2023;11). |
DrugClasses | CD20 Antibody 24 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
INT2104 | INT2104 | 0 | 1 |